409 related articles for article (PubMed ID: 15660527)
1. Aptamers: an emerging class of therapeutics.
Nimjee SM; Rusconi CP; Sullenger BA
Annu Rev Med; 2005; 56():555-83. PubMed ID: 15660527
[TBL] [Abstract][Full Text] [Related]
2. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
[TBL] [Abstract][Full Text] [Related]
3. Aptamers: the emerging class of future anticoagulation for vascular disease.
Kuliczkowski W; Floyd J; Malinin A; Serebruany V
Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):503-7. PubMed ID: 20397824
[TBL] [Abstract][Full Text] [Related]
4. The potential of aptamers as anticoagulants.
Nimjee SM; Rusconi CP; Harrington RA; Sullenger BA
Trends Cardiovasc Med; 2005 Jan; 15(1):41-5. PubMed ID: 15795162
[TBL] [Abstract][Full Text] [Related]
5. Development of universal antidotes to control aptamer activity.
Oney S; Lam RT; Bompiani KM; Blake CM; Quick G; Heidel JD; Liu JY; Mack BC; Davis ME; Leong KW; Sullenger BA
Nat Med; 2009 Oct; 15(10):1224-8. PubMed ID: 19801990
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: RNA aptamers.
Que-Gewirth NS; Sullenger BA
Gene Ther; 2007 Feb; 14(4):283-91. PubMed ID: 17279100
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
8. [Oligonucleotide therapeutics - an emerging novel class of compounds].
Wacheck V
Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid aptamers in human viral disease.
Zhang Z; Blank M; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2004; 52(5):307-15. PubMed ID: 15507871
[TBL] [Abstract][Full Text] [Related]
10. Aptamers: from bench side research towards patented molecules with therapeutic applications.
Majumder P; Gomes KN; Ulrich H
Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
[TBL] [Abstract][Full Text] [Related]
11. Aptamers: selected oligonucleotides for therapy.
Toulmé JJ
Curr Opin Mol Ther; 2000 Jun; 2(3):318-24. PubMed ID: 11249626
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of synthetic nucleic acid aptamers.
Poolsup S; Kim CY
Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
[TBL] [Abstract][Full Text] [Related]
13. First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
Dyke CK; Steinhubl SR; Kleiman NS; Cannon RO; Aberle LG; Lin M; Myles SK; Melloni C; Harrington RA; Alexander JH; Becker RC; Rusconi CP
Circulation; 2006 Dec; 114(23):2490-7. PubMed ID: 17101847
[TBL] [Abstract][Full Text] [Related]
14. Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.
Musumeci D; Montesarchio D
Pharmacol Ther; 2012 Nov; 136(2):202-15. PubMed ID: 22850531
[TBL] [Abstract][Full Text] [Related]
15. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
16. Development of aptamer therapeutics.
Bunka DH; Platonova O; Stockley PG
Curr Opin Pharmacol; 2010 Oct; 10(5):557-62. PubMed ID: 20638902
[TBL] [Abstract][Full Text] [Related]
17. Locked nucleic acid aptamers.
Barciszewski J; Medgaard M; Koch T; Kurreck J; Erdmann VA
Methods Mol Biol; 2009; 535():165-86. PubMed ID: 19377996
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid aptamers as adjuncts to vaccine development.
Becker KC; Becker RC
Curr Opin Mol Ther; 2006 Apr; 8(2):122-9. PubMed ID: 16610764
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acids delivering nucleic acids.
Catuogno S; Esposito CL; Condorelli G; de Franciscis V
Adv Drug Deliv Rev; 2018 Sep; 134():79-93. PubMed ID: 29630917
[TBL] [Abstract][Full Text] [Related]
20. Emerging applications of aptamers for anticoagulation and hemostasis.
Chabata CV; Frederiksen JW; Sullenger BA; Gunaratne R
Curr Opin Hematol; 2018 Sep; 25(5):382-388. PubMed ID: 30015643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
